Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016 (2016), Article ID 8246839, 7 pages
http://dx.doi.org/10.1155/2016/8246839
Research Article

Redox Status of β2GPI in Different Stages of Diabetic Angiopathy

1Key Laboratory of Hormones and Development (Ministry of Health), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300070, China
2Tianjin Haibin People’s Hospital, Tianjin, China

Received 16 June 2016; Accepted 9 August 2016

Academic Editor: Giuseppe Murdaca

Copyright © 2016 Jun Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Ioannou, J.-Y. Zhang, M. Qi et al., “Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein i,” Arthritis and Rheumatism, vol. 63, no. 9, pp. 2774–2782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. F. H. Passam, S. Rahgozar, M. Qi et al., “Beta 2 glycoprotein I is a substrate of thiol oxidoreductases,” Blood, vol. 116, no. 11, pp. 1995–1997, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Ioannou, J.-Y. Zhang, F. H. Passam et al., “Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury,” Blood, vol. 116, no. 11, pp. 1961–1970, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W.-L. Wang, Z.-X. Meng, S.-J. Zhou et al., “Reduced beta2-glycoprotein i protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis,” Lipids in Health and Disease, vol. 12, no. 1, article 174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Sheng, J. G. Hanly, S. W. Reddel et al., “Detection of ‘antiphospholipid’ antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding β2-glycoprotein I and prothrombin,” Clinical and Experimental Immunology, vol. 124, no. 3, pp. 502–508, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kouts, M.-X. Wang, S. Adelstein, and S. A. Krilis, “Immunization of a rabbit with β2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies,” Journal of Immunology, vol. 155, no. 2, pp. 958–966, 1995. View at Google Scholar · View at Scopus
  8. P. G. Vlachoyiannopoulos, S. A. Krilis, J. E. Hunt, M. N. Manoussakis, and H. M. Moutsopoulos, “Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and β2-glycoprotein-I plasma levels,” European Journal of Clinical Investigation, vol. 22, no. 7, pp. 482–487, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Lin, R. Murphy, B. White et al., “Circulating levels of β2-glycoprotein I in thrombotic disorders and in inflammation,” Lupus, vol. 15, no. 2, pp. 87–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Ç. Agar, P. G. de Groot, M. Mörgelin et al., “β2-glycoprotein I: a novel component of innate immunity,” Blood, vol. 117, no. 25, pp. 6939–6947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Rand, “A new fish for the β2GPI hook: LPS!,” Blood, vol. 117, no. 25, pp. 6743–6744, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Buttari, E. Profumo, V. Mattei et al., “Oxidized β2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response,” Blood, vol. 106, no. 12, pp. 3880–3887, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Cook and P. J. Hogg, “Post-translational control of protein function by disulfide bond cleavage,” Antioxidants and Redox Signaling, vol. 18, no. 15, pp. 1987–2015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Azimi, J. W. H. Wong, and P. J. Hogg, “Control of mature protein function by allosteric disulfide bonds,” Antioxidants and Redox Signaling, vol. 14, no. 1, pp. 113–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Castro, I. Lázaro, D. M. Selva et al., “APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome,” Atherosclerosis, vol. 209, no. 1, pp. 201–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Zhang, S.-J. Zhou, C.-J. Li et al., “C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein i complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway,” Lipids in Health and Disease, vol. 12, article 42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Steinberg, S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum, “Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity,” The New England Journal of Medicine, vol. 320, no. 14, pp. 915–924, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Profumo, B. Buttari, C. Alessandri et al., “Beta2-glycoprotein I is a target of t cell reactivity in patients with advanced carotid atherosclerotic plaques,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 1, pp. 73–80, 2010. View at Google Scholar · View at Scopus
  19. V. X. Du, G. van Os, J. A. Kremer Hovinga et al., “Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura,” British Journal of Haematology, vol. 159, no. 1, pp. 94–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. J. J. Hulstein, P. J. Lenting, B. De Laat, R. H. W. M. Derksen, R. Fijnheer, and P. G. De Groot, “β2-Glycoprotein I inhibits vonWillebrand factor-dependent platelet adhesion and aggregation,” Blood, vol. 110, no. 5, pp. 1483–1491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. F. H. Passam, S. Rahgozar, M. Qi et al., “Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1,” Journal of Thrombosis and Haemostasis, vol. 8, no. 8, pp. 1754–1762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. F. H. Passam, J. C. Qi, K. Tanaka, K. I. Matthaei, and S. A. Krilis, “In vivo modulation of angiogenesis by beta 2 glycoprotein I,” Journal of Autoimmunity, vol. 35, no. 3, pp. 232–240, 2010. View at Publisher · View at Google Scholar · View at Scopus